Zobrazeno 1 - 6
of 6
pro vyhledávání: '"Kemal, Kural"'
Publikováno v:
Haseki Tıp Bülteni, Vol 60, Iss 1, Pp 1-6 (2022)
Aim:Breast cancer is the most prevalent cancer diagnosed in women. Screening programs to diagnose breast anomalies increase the likelihood of early diagnosis and survival. This study describes the most extensive breast cancer screening program in Ist
Externí odkaz:
https://doaj.org/article/6cca846166794b6fab0f8ad007c69542
Autor:
Perihan Alkan, Kemal Kural, Mustafa Hatipoglu, Abdullah Emre Güner, Suayip Birinci, Kemal Memisoglu, Aral Sürmeli, Işıl Maral, Erdoğan Kocayiğit, Esra Şahin
Publikováno v:
Turkish Journal of Medical Sciences
Background/aim: COVID-19 has now become a global pandemic. Understanding the routes of transmission is vital in the mitigation and suppression of the disease. Istanbul has become one of the disease's epicenters. This study aims to describe the first
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::14bbc9e8a5d4c65e5a1a4a4d2bc4711e
https://doi.org/10.3906/sag-2103-30
https://doi.org/10.3906/sag-2103-30
Publikováno v:
Northern Clinics of Istanbul.
Earlier detection and timely interventions against cancers are well known to reduce the morbidity and mortality. Screening programs provide opportunity to detect cancers as early as precancerous stages. Cancers of cervix of uterus are one of the canc
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::1be52fb3b3e81e839295b130d3849cde
https://doi.org/10.14744/nci.2022.74507
https://doi.org/10.14744/nci.2022.74507
Autor:
Kemal Kural, Serdal Zelyurt, Esra Şahin, Abdullah Emre Güner, Kemal Memisoglu, Habip Yilmaz, Erdoğan Kocayiğit, Aral Sürmeli, Perihan Alkan, Cemal Kazezoglu, Işıl Maral
Publikováno v:
Northern Clinics of Istanbul
OBJECTIVE: The objective of this study was to understand the observational relationship between adoption of favipiravir into the national COVID-19 treatment protocol and intensive care unit (ICU) admission rates in Istanbul due to COVID-19. METHODS:
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::e4b51b5451962c0febb289546fd83c19
https://doi.org/10.14744/nci.2021.60420
https://doi.org/10.14744/nci.2021.60420
Autor:
Kemal Kural, Mehmet Sert, Seymen Bora, Hüseyin Gülay, Aykut Sifil, Koray Atila, Taner Camsari, Pinar Ataca, Ali Çelik, Sibel Ersan, Caner Çavdar
In this retrospective study, 83 patients were accepted. Mammalian target of rapamycin (mTOR) group consisting of 37 patients were converted from calcineurin inhibitors (CNI), and the control group included 46 patients (initially CNI-receiving patient
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::8c49a7b7c069a43d753aa52c1f8d3156
https://avesis.deu.edu.tr/publication/details/f14ce917-6882-471c-9817-f21b77b55053/oai
https://avesis.deu.edu.tr/publication/details/f14ce917-6882-471c-9817-f21b77b55053/oai
Publikováno v:
European Journal of Internal Medicine. 20:S264
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::023cddb7cc5eec23847f31970b9e0052
https://doi.org/10.1016/s0953-6205(09)60832-3
https://doi.org/10.1016/s0953-6205(09)60832-3